Cabaletta Bio

Contributing Author

Recent Articles by Cabaletta Bio

Jun-11	Cabaletta Bio Announces Pricing of Public Offering of Securities CABA GlobeNewswire
Jun-11	Cabaletta Bio Announces Proposed Public Offering of Securities CABA GlobeNewswire
Jun-11	Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress CABA GlobeNewswire
May-29	Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference CABA GlobeNewswire
May-15	Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts CABA GlobeNewswire